Virax Biolabs
VRAX----
Virax Biolabs (VRAX)
Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Virax Biolabs Analyst Rating
View MoreForecast & Rating
Jan 9, 2026Price forecast
$25.00683.70%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 1 day ago, 04:13 AM
Cross-border spillovers and policy repricing: Structural divergence in 9 niche US assets
- rttnews · Jul 16 at 09:58 PM
Top Biotech Gainers: CDNA Soars On Medicare Policy, ATAI Acquired, ABT Lifts Outlook, APLM On Watch
- US Stock Market Update · Jul 16 at 01:40 PM
Virax Biolabs surges 10% during regular trading to $3.81
- US Stock Market Update · Jul 16 at 09:21 AM
Virax Biolabs climbs 7% during trading on Fosun Diagnostics supply deal
- PUBT · Jul 16 at 06:33 AM
Virax Biolabs signs Fosun Diagnostics supply deal for ImmuneSelect in six Southeast Asian markets
- StockTitan · Jul 15 at 10:30 PM
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement | VRAX Stock News
